PRIMOPUS
LIVE

Serial Number

79373510

Owner

Imaginarium Future Limited

Attorney

Joseph G. Chu

Filing Date

Dec 9, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PRIMOPUS Trademark

Serial Number: 79373510 • Registration: 7741406

PRIMOPUS is a trademark filed by Imaginarium Future Limited on December 9, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Imaginarium Future Limited

The Stables,

Entity Type: 99

Trademark Details

Filing Date

December 9, 2022

Registration Date

April 1, 2025

Published for Opposition

February 11, 2025

Goods & Services

Custom manufacture of pharmaceuticals and of pharmaceutical formulations; custom manufacture of pharmaceuticals and biopharmaceuticals, namely, active pharmaceuticals

Pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, ocular, and bacteria-based related diseases and disorders, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations, and vaccines, and sanitary preparations for medical use; chemical, biochemical and biological products namely chemical, biochemical and biological reagents for medical use; agrochemical preparations in the nature of fungicides and herbicides

Research and development of pharmaceuticals and biopharmaceuticals, namely, active pharmaceuticals for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, ocular, and bacteria-based related diseases and disorders, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations, and vaccines

Chemical, biochemical and biological products for use in industry, science and scientific research, namely, chemical preparations for use in industry, biochemical preparations for scientific purposes, biological preparations for use in industry and science; diagnostic agents and reagents for use in industrial use, namely, for use in the manufacture of pharmaceuticals, and in science and research; chemical and biological products and solutions in the nature of chemicals, namely, Fmoc amino acids and phosphoramidites for use in science and in the manufacture of pharmaceuticals

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 31, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 9, 2025 FICS
FINAL DISPOSITION PROCESSED
Oct 9, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 1, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 1, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 1, 2025 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 28, 2025 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 5, 2025 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 3, 2025 OPNR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 16, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 17, 2024 GNFN
FINAL REFUSAL E-MAILED
Jul 17, 2024 GNFR
FINAL REFUSAL WRITTEN
Jul 17, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2024 CRFA
ASSIGNED TO LIE
Jun 17, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 31, 2024 TROA
PETITION TO REVIVE-GRANTED
May 31, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
May 31, 2024 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 12, 2024 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 12, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 12, 2024 ABN2
ATTORNEY REVIEW COMPLETED
Oct 31, 2023 ATRV
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 29, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 29, 2023 RFRR
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Sep 29, 2023 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Sep 24, 2023 LIMG
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 16, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 15, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 11, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 6, 2023 REPR